Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older

IMPORTANCE: Every year, influenza vaccines are administered to millions of people worldwide to reduce morbidity and mortality from influenza. As new vaccine formulations are increasingly used, monitoring and comparing safety, in addition to vaccine effectiveness, in target populations are essential....

Descripción completa

Detalles Bibliográficos
Autores principales: Pillsbury, Alexis J., Fathima, Parveen, Quinn, Helen E., Cashman, Patrick, Blyth, Christopher C., Leeb, Alan, Macartney, Kristine K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201308/
https://www.ncbi.nlm.nih.gov/pubmed/32369177
http://dx.doi.org/10.1001/jamanetworkopen.2020.4079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201308/
https://www.ncbi.nlm.nih.gov/pubmed/32369177
http://dx.doi.org/10.1001/jamanetworkopen.2020.4079

Ejemplares similares